MARKET

ONC

ONC

BeOne Medicines Ltd.
NASDAQ
362.39
+2.42
+0.67%
Opening 11:47 09/25 EDT
OPEN
362.51
PREV CLOSE
359.97
HIGH
365.00
LOW
358.51
VOLUME
76.03K
TURNOVER
--
52 WEEK HIGH
385.22
52 WEEK LOW
253.95
MARKET CAP
41.20B
P/E (TTM)
63.85
1D
5D
1M
3M
1Y
5Y
1D
BeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B2033
TipRanks · 2d ago
Sonrotoclax Safety Study Completion Signals Next Steps for BeOne Medicines
TipRanks · 4d ago
Weekly Report: what happened at ONC last week (0914-0918)?
Weekly Report · 4d ago
BeOne Medicines (ONC) Rebranded And Lifted Guidance, Is It Still Cheap?
Simply Wall St · 6d ago
Tracking Baker Brothers' Portfolio: Q2 2026 Update
Seeking Alpha · 09/16 23:46
Is BeOne Medicines (ONC) Reasonably Priced Or Looking Rich On Earnings?
Simply Wall St · 09/15 23:22
Weekly Report: what happened at ONC last week (0907-0911)?
Weekly Report · 09/14 09:14
How Investors Are Reacting To BeOne Medicines (ONC) Positive Cancer Trial Results
Simply Wall St · 09/13 14:17
More
About ONC
BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.

Webull offers BeOne Medicines AG (ADR) stock information, including NASDAQ: ONC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONC stock methods without spending real money on the virtual paper trading platform.